77 results
DEFA14A
ALGS
Aligos Therapeutics Inc
29 Apr 24
Additional proxy soliciting materials
4:04pm
& Young LLP, as our independent registered public accounting firm for the year ending December 31, 2024;
3. The amendment of our Amended and Restated
PRE 14A
ALGS
Aligos Therapeutics Inc
16 Apr 24
Preliminary proxy
5:27pm
are elected;
To ratify the appointment, by the Audit Committee of the Company’s Board of Directors, of Ernst & Young LLP, as the independent registered public … , FOR the ratification of the appointment of Ernst & Young LLP, as the independent registered public accounting firm, as described in Proposal No. 2
S-8
EX-23.2
ALGS
Aligos Therapeutics Inc
12 Mar 24
Registration of securities for employees
4:51pm
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement
S-8
opzkpsh3e s1w1
12 Mar 24
Registration of securities for employees
4:51pm
SC TO-I
EX-99
6o95j
30 Jan 24
Issuer tender offer statement
7:04am
424B3
gjgb 5wd5ac
28 Nov 23
Prospectus supplement
4:01pm
8-K
EX-4.2
grffrr
25 Oct 23
Entry into a Material Definitive Agreement
5:05pm
8-K
EX-10.1
cla afxmp6bu67rsdqw3
25 Oct 23
Entry into a Material Definitive Agreement
5:05pm
8-K
5utptti3lxm9qlc
25 Jul 23
Submission of Matters to a Vote of Security Holders
4:02pm